Samsung Biologics Korean Stocks Hit Record Q2 Profit of 586.4B Won
Samsung Biologics posted record Q2 results with revenue of 1.3209 trillion won and operating profit of 586.4 billion won, the company announced on the 23rd. Revenue increased 30.2% and operating profit rose 22.9% compared to the same period last year. The performance was driven by full operation of
Samsung Biologics-4.54%
GateMacroTradfiHub·07-23 09:27
